GW7647 monotreatment also suppressed phosphorylation of NF-κB p65, IRS-1 (at ser 636/639) and eIF2α, but not clearly ameliorated NASH. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.